有効性評価に基づく肺がん検診ガイドライン

添付書類2

添付書類2　最終追加文献リスト

英22文献

No	Author	Title	Journal	Volume	Page	Year
22	Kubik A, Polák J.	Lung cancer detection: results of a randomized prospective study in Czechoslovakia.	Cancer	57	2427-37	1986
37	Tockman MS	Survival and mortality from lung cancer in a screened population: the Johns Hopkins Study.	Chest	89	324S-5S	1986
49	Naruke T, Kuroishi T, Suzuki T, Ikeda S.	Comparative study of survival of screen-detected compared with symptom-detected lung cancer cases.	Seminars in Surg Oncol	9	80-4	1993
51	Nishizawa K, Iwai K, Matsumoto T, Sakashita K, Iinuma TA,Tateno Y, Miyamoto T, Shimura A, Takagi H.	Estimation of the Exposure and a Risk-Benefit Analysis for a CT System Designed for a Lung Cancer Mass Screening Unit.	Radiat Prot Dosimetry	67	101-8	1996
56	Sobue T, Suzuki T, Matsuda M, Kuroishi T, Ikeda S, Naruke T, The Japanese Lung Cancer Screening Research Group.	Survival for Clinical stage I lung cancer not surgically treated: comparison between screen-detected and symptom-detected cases.	Cancer	69(3)	685-92	1992
57	Motohiro A, Ueda H, Komatsu H, Yanai N, Mori T; National Chest Hospital Study Group for Lung Cancer.	Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan.	Lung Cancer	36(1)	65-9	2002
58	Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P; Writing Committee, Lung Screening Study Research Group.	Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.	Chest	126	114-21	2004
60	Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS, Clayton AC, Pairolero PC.	Screening for lung cancer with low-dose spiral computed tomography.	Am J Respir Crit Care Med	165	508-513	2002
63	Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, Hasegawa M, Yamanda T, Kubo K, Hanamura K, Asakura K.	Mass screening for lung cancer with mobile spiral computed tomography scanner.	Lancet	351	1242-1245	1998
66	Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, Libby D, Pasmantier M, Vazquez M, Koizumi J, Flieder D, Altorki N, Miettinen OS.	Early lung cancer action project: initial findings on repeat screenings.	Cancer	92	153-159	2001
68	Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H.	Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies.	Chest	122	15-20	2002
75	Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Kusunoki Y, Nakayama T, Imamura F.	Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years.	Ann Thorac Surg	73	386-93	2002
79	Pue CA, Pacht ER.	Complications of fiberoptic bronchoscopy at a University Hospital.	Chest	107	430-2	1995
81	Cox JE, Chiles C, McManus CM, Aquino SL, Choplin RH.	Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax.	Radiology	21	165-8	1999
82	Arslan S, Yilmaz A, Bayramgürler B, Uzman Ö, Ü nver E, Akkaya E.	CT-guided transthoracic fine needle aspiration of pulmonary lesions: accuracy and complications in 294 patients.	Med Sci Monit	8(7)	493-7	2002
83	Saji H, Nakamura H, Tsuchida T, Tsuboi M, Kawate N, Konaka C, Kato H.	The incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy: the angle of the needle trajectory is a novel predictor.	Chest	121	1521-6	2002
84	Geraghty PR, Kee ST, McFarlane G, Razavi MK, Sze DY, Dake MD.	CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate.	Radiology	229	475-81	2003
85	Choi CM, Um SW, Yoo CG, Kim YW, Han SK, Shim YS, Lee CT.	Incidence and risk factors of delayed pneumothorax after transthoracic needle biopsy of the lung.	Chest	126	1516-21	2004
86	Tomiyama N, Yasuhara Y, Nakajima Y, Adachi S, Arai Y, Kusumoto M, Eguchi K, Kuriyama K, Sakai F, Noguchi M, Murata K, Murayama S, Mochizuki T, Mori K, Yamada K.	CT-guided needle biopsy of lung lesions: A survey of severe complication based on 9783 biopsies in Japan.	Eur J Radiol	May(online)		2006
87	Inderbitzi RG, Grillet MP.	Risk and hazards of video-thoracoscopic surgery: a collective review.	Eur J Cardiothorac Surg	10	483-9	1996
88	Kaiser LR, Bavaria JE.	Complications of thoracoscopy.	Ann Thorac Surg	56(3)	796-8	1993
89	Krasna MJ, Deshmukh S, McLaughlin JS.	Complications of Thoracoscopy.	Ann Thorac Surg	61	1066-9	1996

和13文献

No	Author	Title	Journal	Volume	Page	Year
22	黒石哲生．	検診によってがん死亡率は減少しているか．	日本がん検診・診断学会誌	4	30-2	1996
43	成毛韶夫．	肺がんの集団検診の精度管理と正確な評価に関する研究．	厚生省がん研究助成金による研究報告集平成4年度		558-61	1994
45	田中利彦，井澤　正．	老人保健法に基づく茅ヶ崎医師会の肺がん検診．	プライマリ・ケア	19	37-44	1996
47	西井研治，守谷欣明，正影三恵子，中山富雄，鈴木隆一郎，佐川元保，上岡　博．	肺癌検診の精度管理：感度と特異度の検討．	日本がん検診・診断学会誌	11	33-6	2004
48	佐藤雅美，斎藤泰紀，佐川元保，高橋里美，菅間敬治，中嶋隆太郎，佐藤博，佐藤博俊，大久田和弘，藤村重文．	宮城県肺癌検診高危険群における喀痰細胞診の感度と特異度の検討．	日臨細胞誌	33	448-51	1994
52	村松禎久，秋山典子，花井耕造．	螺旋状（ヘリカル）スキャンを用いた肺がんスクリーニングCTの医療被曝について．	日放技学誌	52	1-8	1996
53	神津省吾，仲尾次政剛．	胸部検診時の被曝線量．	コニカX-レイ写真研究	43(2)	59-60	1992
54	岡本英明，宮崎正義，米田晃敏，鈴木敬一，上田講記，熊谷年起，坂本正利，黒田知純，鈴木隆一郎，松本　徹．	CT肺癌検診の被曝線量．	日放技学誌	57	939-46	2001
71	丸山雄一郎，山本洋，山口敏之，小山正道，久堀周治郎，高野美恵子，生島妙美，望月哲仁，水澤幸博，森泉力．	MDCTを用いた低線量薄層CTによる胸部検診とCT検診車を用いた低線量CTによる胸部検診の比較検討．	胸部CT検診	9	116-21	2002
72	西澤かな枝．	わが国のCT検査の実態と被ばく線量推定．	日本医放会誌	64(7)	suppl.3-6.	2004
76	金子昌弘，相馬一亥，山本記顕，池田茂人．	日本における気管支ファイバースコープ検査の現状―特に合併症について―．	気管支学	5	103-12	1983
80	加藤治文，河手典彦，米山一男，木下孔明．	肺の穿刺生検．	外科	47	1382-5	1985
90	成毛韶夫，末舛恵一，武野良仁．	わが国の胸腔鏡手術の現況．	日本胸部外科学会誌	44(3)	341-2	1996

<前へ次へ>

目次タイトル
メモ（任意）

有効性評価に基づく肺がん検診ガイドライン

ガイドライン解説

診療ガイドライン検索